Table 2. Comparison of efficacy and safety of intravenous LEV and PHT.

Data are n (%) values.

^*Chi-square test, with p≤0.05 considered significant, ^†Patients were monitored for acute responses only, which reduced the number of events reported. No serious event was observed during the short study period.

LEV: levetiracetam, PHT: phenytoin.